Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CTXR Citius Pharmaceuticals Inc

2,79

-0,12 (-4,12%)

30 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Citius Pharmaceuticals Charts.

Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Citius Pharmaceuticals Charts.

News Citius Pharmaceuticals Inc

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Donnerstag 16 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mittwoch 8 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Mittwoch 8 Januar 2025 (3 Wochen vor) • PR Newswire (US)

Form 8-K - Current report
Dienstag 7 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
Dienstag 7 Januar 2025 (3 Wochen vor) • PR Newswire (US)

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives
Montag 6 Januar 2025 (3 Wochen vor) • PR Newswire (US)

Form 8-K - Current report
Freitag 27 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Citius Pharmaceuticals Inc News-Artikel

DekaBank Deutsche Giroze...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen